Why Relate Concentration to Dose?
A concentration by itself does not describe how much drug was given to produce it. When the dose changes, a concentration may change simply because the patient received more or less drug. A concentration-to-dose ratio relates a measured concentration to a specified dose, making it possible to screen for a change in exposure per unit dose. In therapeutic drug monitoring, the most informative comparison is often a patient’s current ratio against that same patient’s earlier ratio, provided the measurements are comparable.
The ratio is a screening summary, not a diagnosis. A higher ratio can flag more measured concentration per unit dose than before, but it cannot determine why. Changes in drug handling, dose-taking, interacting treatments, health status, sampling conditions, or measurement may all contribute. Interpretation therefore starts by defining exactly what goes in the numerator and denominator and checking that the comparison is meaningful.
Define the Ratio Before Calculating It
A ratio is only as clear as its components. The numerator might be a trough concentration, a postdose concentration, or an AUC over a dosing interval. These are different metrics and are not interchangeable. The denominator might be the dose per administration, the total dose in a dosing interval, or the total daily dose. A ratio calculated with one convention cannot be directly compared with a ratio calculated using another.
For a concentration in mg/L divided by a daily dose in mg/day, the units are day/L. If instead the numerator is an AUC in mg·h/L and the denominator is a dose in mg per interval, the units are h/L. Keeping units visible helps catch mistakes such as dividing by a single dose in one record and by a daily total in another. The dose denominator should refer to what was prescribed or taken according to the monitoring question; those are not necessarily the same quantity.
For within-patient screening, compare like with like: the same concentration metric, compatible dose units and schedule, and a sufficiently comparable measurement process. The intended interpretation is usually a change in exposure per dose, not a comparison of raw ratios across unrelated patients. A population reference range for a ratio is not automatically an individualized target. The earlier material on AUC targets for therapeutic drug monitoring provides the context for choosing an exposure metric; here the task is to normalize a chosen metric by dose.
Worked Example: Calculating a Trough-to-Daily-Dose Ratio
A hypothetical patient has a measured trough concentration of 4.8 mg/L while receiving 300 mg/day. Calculate the trough-to-daily-dose ratio.
Use \(R=C_{\mathrm{trough}}/D_{\mathrm{day}}\). Substituting the values gives:
The result means that the measured trough concentration is 0.0160 day/L per unit of daily dose under this ratio convention. It does not mean the patient’s clearance is known, nor does it establish whether the concentration is appropriate. To use the value as a screening baseline, retain the concentration metric, dose basis, units, and measurement conditions alongside it.
What a Change in the Ratio Can Signal
If the concentration metric and dose denominator are comparable, a higher ratio means a higher measured concentration or exposure per unit dose; a lower ratio means a lower value per unit dose. A change can be calculated either by subtracting the ratios or as a relative percentage:
A within-patient increase can prompt review of the clinical and dosing context and confirmation that the measurements are comparable. It does not, on its own, prove reduced clearance or any other specific mechanism. Likewise, a decrease can prompt a check for explanations of lower exposure per dose, but cannot establish one. There is no universal percentage change that is meaningful for every drug and monitoring setting. The size of a signal must be considered alongside the variability and uncertainty of the concentration measurement and the clinical purpose of monitoring.
Worked Example: Interpreting a Within-Patient Increase
At an earlier assessment, a hypothetical patient had a trough concentration of 4.8 mg/L on 300 mg/day. At a later assessment, the trough was 7.2 mg/L on the same daily dose. Assume the same concentration metric and comparable measurement conditions. Calculate both ratios and the relative change.
The baseline ratio is \(4.8/300=0.0160\) day/L. The later ratio is \(7.2/300=0.0240\) day/L. Thus:
The later ratio is 50.0% higher than the baseline ratio. Because the daily dose is unchanged, this is a screening signal of a higher measured trough per unit daily dose. It does not show why the ratio increased. The result should prompt contextual review and, where appropriate, confirmation rather than an assumption about cause or an automatic dose change.
A Useful Derivation for AUC-to-Dose Ratios
For some monitoring questions, an AUC-to-dose ratio has a direct interpretation under a simple pharmacokinetic model. Suppose drug disposition is linear over the relevant range, the patient is at steady state, and AUC covers a complete dosing interval of length \(\tau\). Let \(D\) be the dose administered over that interval, \(F\) the fraction of the dose reaching systemic circulation, and \(CL\) systemic clearance. Under these assumptions, the amount entering the systemic circulation over the interval is \(FD\), and the amount eliminated during the interval equals that input at steady state.
For linear elimination, the amount eliminated over the interval is \(CL\) multiplied by the AUC over that interval. Equating input and elimination gives:
Thus, under these assumptions, AUC per dose is proportional to bioavailability and inversely proportional to clearance. For intravenous administration, \(F=1\). For an orally administered drug, a change in either bioavailability or clearance can change the ratio. This derivation explains why the AUC-to-dose ratio can be useful as a screening measure; it also shows why the ratio alone cannot distinguish its contributing factors. The relationship does not automatically apply to a single concentration-to-dose ratio, to incomplete AUC coverage, or when the stated linear and steady-state assumptions are not met.
Worked Example: Comparing AUC-to-Dose Ratios
In a hypothetical monitoring record, a patient’s AUC over a complete dosing interval is 72 mg·h/L after a total interval dose of 600 mg. At a later comparable assessment, the AUC is 90 mg·h/L after the same interval dose. Calculate the ratios and interpret the change. Assume linear pharmacokinetics and that each AUC represents a complete interval under comparable conditions.
The baseline AUC-to-dose ratio is:
The later ratio is \(90/600=0.150\) h/L. The relative change is:
The later AUC per dose is 25.0% higher. Under the stated model assumptions, this signals a change in the combined quantity \(F/CL\); it does not reveal whether bioavailability, clearance, or both changed. The calculation also does not establish that the change is clinically important. Its significance depends on the drug-specific monitoring context and the uncertainty of the AUC estimates.
Assumptions, Diagnostics, and Alternatives
A ratio comparison is most useful when the numerator and denominator are well defined and the measurements are comparable. Before interpreting a change, check the following:
- Metric consistency: confirm that both numerators represent the same kind of concentration or exposure measure, rather than comparing, for example, a trough with an AUC.
- Dose consistency: confirm that the denominator uses the same basis in both records, such as total daily dose or dose per interval, with matching units.
- Comparable measurement conditions: determine whether the samples and exposure estimates were obtained in sufficiently comparable circumstances for the intended interpretation. A difference in collection or estimation conditions can create an apparent ratio change.
- Model suitability: an AUC-to-dose interpretation as \(F/CL\) requires the stated assumptions, including linear pharmacokinetics and a complete interval at steady state. If those conditions are doubtful, do not use that mechanistic interpretation.
- Signal size and uncertainty: consider whether the observed change is large relative to plausible measurement and within-patient variation. A small numerical difference is not automatically a meaningful signal.
A concentration-to-dose ratio is compact and convenient, especially for tracking a patient’s own results over time. But it compresses information: it does not explain the cause of a change and does not replace review of the concentration itself, the dose history, clinical context, or a suitable pharmacokinetic analysis. Depending on the monitoring question, alternatives include comparing the measured concentration with an individualized target, evaluating an exposure metric such as AUC, or using a model that represents relevant patient and dosing information. These approaches answer different questions; none should be selected solely because its calculation is convenient.
Using the Ratio Responsibly
The ratio’s main value is as a consistent summary for screening, particularly when a patient has a useful prior measurement for comparison. It can help identify a result that deserves attention even when the dose has changed, because it places concentration in relation to dose. However, the ratio is not a stand-alone dosing rule, a universal therapeutic target, or proof of a pharmacokinetic mechanism. Any clinical decision must be based on the relevant target, the reliability and context of the measurements, and the patient’s overall situation.
A practical report should state the numerator, denominator, units, ratio, and comparator. For example: “Trough concentration-to-daily-dose ratio was 0.0240 day/L, 50.0% above this patient’s earlier value of 0.0160 day/L; the change is a screening signal and does not establish its cause.” Such wording makes both the calculation and its limits explicit.
Check Your Understanding
Work through these questions, then compare your reasoning with the solutions.
- A hypothetical patient has a concentration of 6.0 mg/L on 400 mg/day. Calculate the concentration-to-daily-dose ratio and state its units.
- A patient’s ratio changes from 0.020 day/L to 0.015 day/L. Calculate the percentage change and interpret its direction.
- Why is it invalid to compare a trough-to-daily-dose ratio directly with an AUC-to-interval-dose ratio?
- Under what assumptions does \(AUC_{\tau}/D=F/CL\) hold, and what does an increase in that ratio establish?
- A higher ratio is observed on two comparable assessments. Name one conclusion supported by the calculation and one conclusion it does not support.
Solutions. (1) \(6.0/400=0.0150\) day/L. (2) \((0.015-0.020)/0.020\times100\%=-25.0\%\), so the ratio decreased by 25.0%; it indicates less measured concentration per unit daily dose, not its cause. (3) Their numerators are different exposure metrics and their denominators use different dose bases, so the ratios have different meanings and units. (4) The relationship requires linear pharmacokinetics, steady state, and an AUC over a complete dosing interval, with \(F\) defined for the route and dose. An increase establishes a higher \(F/CL\) under those assumptions, not whether \(F\), \(CL\), or both changed. (5) It supports the conclusion that measured concentration or exposure per unit dose increased under the stated comparison; it does not establish a specific cause such as reduced clearance.